Search results
Results from the Tech24 Deals Content Network
Bristol Myers Squibb stock tanked in April after management lowered the midpoint of its earnings outlook for 2024 from $7.25 per share to just $0.55 to account for a $12.1 billion IPRD charge ...
For premium support please call: 800-290-4726 more ways to reach us
Friday, Bristol Myers Squibb & Co (NYSE:BMY) posted second-quarter revenues of $12.20 billion, beating the consensus of $11.55 billion, an increase of 9% year-over-year, or 11% when adjusted for ...
The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb ( BMS ), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, [ 2] BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.
Bristol-Myers Squibb (BMY) closed at $60.50 in the latest trading session, marking a -1.59% move from the prior day.
In the latest trading session, Bristol-Myers Squibb (BMY) closed at $63.50, marking a -0.5% move from the previous day.
Bristol-Myers Squibb (BMY) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes. Bristol-Myers Squibb (BMY) Catches Eye: Stock Jumps 6.8% Skip to main content
Let's see if Bristol-Myers Squibb Company (BMY) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.